These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12917432)

  • 21. Binding of prion protein to lipid membranes and implications for prion conversion.
    Sanghera N; Pinheiro TJ
    J Mol Biol; 2002 Feb; 315(5):1241-56. PubMed ID: 11827491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conformational transitions in peptides containing two putative alpha-helices of the prion protein.
    Zhang H; Kaneko K; Nguyen JT; Livshits TL; Baldwin MA; Cohen FE; James TL; Prusiner SB
    J Mol Biol; 1995 Jul; 250(4):514-26. PubMed ID: 7542350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways.
    Natalello A; Prokorov VV; Tagliavini F; Morbin M; Forloni G; Beeg M; Manzoni C; Colombo L; Gobbi M; Salmona M; Doglia SM
    J Mol Biol; 2008 Sep; 381(5):1349-61. PubMed ID: 18619462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Spectroscopic characterization of conformational differences between PrPC and PrPSc: an alpha-helix to beta-sheet transition.
    Baldwin MA; Pan KM; Nguyen J; Huang Z; Groth D; Serban A; Gasset M; Mehlhorn I; Fletterick RJ; Cohen FE
    Philos Trans R Soc Lond B Biol Sci; 1994 Mar; 343(1306):435-41. PubMed ID: 7913763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structural analysis of prion proteins by means of drift cell and traveling wave ion mobility mass spectrometry.
    Hilton GR; Thalassinos K; Grabenauer M; Sanghera N; Slade SE; Wyttenbach T; Robinson PJ; Pinheiro TJ; Bowers MT; Scrivens JH
    J Am Soc Mass Spectrom; 2010 May; 21(5):845-54. PubMed ID: 20206551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prion protein selectively binds copper(II) ions.
    Stöckel J; Safar J; Wallace AC; Cohen FE; Prusiner SB
    Biochemistry; 1998 May; 37(20):7185-93. PubMed ID: 9585530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cryptic epitopes in N-terminally truncated prion protein are exposed in the full-length molecule: dependence of conformation on pH.
    Matsunaga Y; Peretz D; Williamson A; Burton D; Mehlhorn I; Groth D; Cohen FE; Prusiner SB; Baldwin MA
    Proteins; 2001 Aug; 44(2):110-8. PubMed ID: 11391773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-assembly of recombinant prion protein of 106 residues.
    Baskakov IV; Aagaard C; Mehlhorn I; Wille H; Groth D; Baldwin MA; Prusiner SB; Cohen FE
    Biochemistry; 2000 Mar; 39(10):2792-804. PubMed ID: 10704232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate.
    Safar J; Roller PP; Gajdusek DC; Gibbs CJ
    Biochemistry; 1994 Jul; 33(27):8375-83. PubMed ID: 8031772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for stepwise formation of amyloid fibrils by the mouse prion protein.
    Jain S; Udgaonkar JB
    J Mol Biol; 2008 Oct; 382(5):1228-41. PubMed ID: 18687339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of a polymerized prion protein.
    Lu BY; Chang JY
    Biochem J; 2002 May; 364(Pt 1):81-7. PubMed ID: 11988079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissociation of recombinant prion protein fibrils into short protofilaments: implications for the endocytic pathway and involvement of the N-terminal domain.
    Qi X; Moore RA; McGuirl MA
    Biochemistry; 2012 Jun; 51(22):4600-8. PubMed ID: 22591453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The burst-phase intermediate in the refolding of beta-lactoglobulin studied by stopped-flow circular dichroism and absorption spectroscopy.
    Kuwajima K; Yamaya H; Sugai S
    J Mol Biol; 1996 Dec; 264(4):806-22. PubMed ID: 8980687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of prion proteins to lipid membranes.
    Critchley P; Kazlauskaite J; Eason R; Pinheiro TJ
    Biochem Biophys Res Commun; 2004 Jan; 313(3):559-67. PubMed ID: 14697227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational polymorphism of the amyloidogenic peptide homologous to residues 113-127 of the prion protein.
    Satheeshkumar KS; Jayakumar R
    Biophys J; 2003 Jul; 85(1):473-83. PubMed ID: 12829502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Slow spontaneous α-to-β structural conversion in a non-denaturing neutral condition reveals the intrinsically disordered property of the disulfide-reduced recombinant mouse prion protein.
    Sang JC; Lee CY; Luh FY; Huang YW; Chiang YW; Chen RP
    Prion; 2012; 6(5):489-97. PubMed ID: 22987112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assemblages of prion fragments: novel model systems for understanding amyloid toxicity.
    Satheeshkumar KS; Murali J; Jayakumar R
    J Struct Biol; 2004 Nov; 148(2):176-93. PubMed ID: 15477098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prion protein alpha-to-beta transition monitored by time-resolved Fourier transform infrared spectroscopy.
    Ollesch J; Künnemann E; Glockshuber R; Gerwert K
    Appl Spectrosc; 2007 Oct; 61(10):1025-31. PubMed ID: 17958950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
    El Moustaine D; Perrier V; Smeller L; Lange R; Torrent J
    FEBS J; 2008 May; 275(9):2021-31. PubMed ID: 18355314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autocatalytic conversion of recombinant prion proteins displays a species barrier.
    Baskakov IV
    J Biol Chem; 2004 Feb; 279(9):7671-7. PubMed ID: 14668351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.